UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.74 +0.26 (+0.33%) GOLD FUTURES
2,321.90 -9.30 (-0.40%) DOW
38,911.81 +59.54 (+0.15%) Bitcoin GBP
50,862.09 +173.07 (+0.34%)
NovoCure Limited (NVCR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:26PM EDT. Market open.
| Previous close | 15.55 |
| Open | 15.33 |
| Bid | 15.48 x 400 |
| Ask | 15.54 x 100 |
| Day's range | 15.33 - 16.25 |
| 52-week range | 10.87 - 83.60 |
| Volume | |
| Avg. volume | 1,304,342 |
| Market cap | 1.671B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
- GuruFocus.com
NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
- Zacks
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.